Comparative oncology seeks to investigate cancer diagnostics, treatments and prevention in all species in hopes that new technologies and treatments can be developed faster and translated into both the veterinary care of companion animals as well as preliminary data that can inform human clinical trials....
The National Institutes of Health has launched a clinical trials network to evaluate emerging technologies for cancer screening. The Cancer Screening Research Network (CSRN) will support the Biden-Harris administration’s Cancer Moonshot℠ by investigating how to identify cancers earlier, when they may be easier to treat....
At Alumni Park, University of Wisconsin–Madison students past, present and future stop to take pictures of the lines radiating from a Numen Lumen seal set into the sidewalk. One line notes the exact distance — 9,181 miles — from Madison to the South Pole, where UW...
UW Carbone Cancer Center patient Gary Davey struggled with metastatic prostate cancer until a clinical trial brought new hope....
Precision medicine has emerged as a game-changer, revolutionizing the landscape of clinical trials and offering new hope for advancement of critical medicines. However, the intricate nature of precision medicine requires precision-based solutions for trial sponsors, clinical research organizations (CROs), labs, and research sites....
The Blue Ridge Institute for Medical Research (BRIMR) has listed the University of Wisconsin Department of Medicine as 12th in the nation for departments of internal medicine receiving research funding from the National Institutes of Health (NIH) in 2023....
The ongoing effort to make Wisconsin a nationally recognized technology hub could get a $7.5 million boost from state funds following the passage of a bill designed to help Wisconsin compete for up to $70 million in federal funds. ...
2024 is a critical year for professionals throughout the clinical research enterprise to build on the momentum gained in 2023 for improving diversity, equity, and inclusion (DEI) among clinical trials participants and other stakeholders. ...
The US Food and Drug Administration (FDA) is focusing on how artificial intelligence (AI) can be used to support clinical trials but says it will take time to get there....
At the Universities of Wisconsin Board of Regents meeting on Friday, Feb. 9, experts gathered to discuss the university’s strategy for maximizing federal funding through burgeoning public-private partnerships, a crucial component of the national push for innovation and economic development....
